Product image of Memantina Normon (Memantine Hydrochloride) supplied by GNH India

Memantina Normon

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantina Normon (Memantine Hydrochloride)

Memantine Hydrochloride, the active ingredient in Memantina Normon, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adults, helping to manage cognitive decline associated with the condition.

GNH India supplies Memantina Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and consistent product quality to meet global healthcare needs and ensuring timely delivery across regions.

Manufacturer / TM Owner

Laboratorios Normon, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Memantina Normon (memantine hydrochloride) acts on the glutamatergic system and is used in dementia care.
  • Alzheimer's disease: improves cognition and functional abilities in patients with moderate to severe disease.

How It Works

  • Memantine hydrochloride binds to the phencyclidine site of NMDA receptors as a non‑competitive antagonist, reducing excessive calcium influx caused by glutamate over‑activation. By moderating excitotoxic neuronal damage, it helps preserve synaptic function and slows the progression of neurodegeneration associated with Alzheimer’s disease.

Side Effects

Memantina Normon may cause a range of adverse reactions.

Common Side Effects

  • Dizziness: transient light‑headedness, especially after dose initiation.
  • Headache: mild to moderate intensity, often resolves with continued therapy.
  • Constipation: reduced bowel motility, manageable with diet or laxatives.
  • Confusion: occasional disorientation, more frequent in early treatment.
  • Hypertension: modest increase in blood pressure in some patients.

Serious or Rare Side Effects

  • Seizures: rare but may occur, requiring immediate medical attention.
  • Cardiac arrhythmia: abnormal heart rhythms reported in isolated cases.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic injury: elevated liver enzymes or hepatitis.
  • Suicidal ideation: emergent thoughts of self‑harm, necessitating prompt evaluation.

Precautions & Warnings

  • When prescribing Memantina Normon, clinicians should consider several safety aspects.
  • Renal impairment: dose adjustment may be required in patients with reduced kidney function.
  • Hepatic disease: monitor liver function tests periodically.
  • History of seizures: use with caution and observe for neurologic changes.
  • Concurrent CNS depressants: may enhance dizziness or sedation.
  • Pregnancy and lactation: safety not established; weigh potential benefits against risks.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Memantina Normon can interact with other medicines; awareness of the interaction level guides management.

Major Interactions (Avoid)

  • Amantadine: combined NMDA antagonism may increase neurotoxicity.
  • Ketamine: additive effects on NMDA blockade can precipitate severe CNS depression.
  • Other NMDA antagonists: concurrent use may lead to excessive inhibition of glutamate signaling.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may diminish cognitive benefits of memantine.
  • CNS depressants (e.g., benzodiazepines): can heighten dizziness or sedation.
  • Diuretics: may alter plasma concentrations of memantine, requiring monitoring.

Frequently Asked Questions

Memantina Normon contains memantine hydrochloride and is used to treat moderate to severe Alzheimer’s disease. It helps improve cognition, memory, and daily functioning by reducing glutamate‑mediated excitotoxicity in the brain.

Memantine hydrochloride acts as a non‑competitive antagonist at the NMDA receptor’s phencyclidine site. By blocking excessive calcium influx caused by over‑activation of glutamate, it protects neurons from excitotoxic damage and supports synaptic stability in Alzheimer’s disease.

The dosage of Memantina Normon is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. The prescriber will set the appropriate dose and titration schedule.

Safety data for memantine hydrochloride in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use only if the potential benefit justifies the potential risk to the fetus or infant.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine reduces glutamate‑induced excitotoxicity. Both classes may be used together for additive benefit in certain patients.

Store Memantina Normon below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not refrigerate or freeze the tablets, and keep them out of reach of children.

Memantina Normon is taken orally, usually as a tablet swallowed with water. The prescriber will advise whether the dose should be taken once daily or divided, and whether it should be taken with or without food.

Serious risks include seizures, severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, cardiac arrhythmias, and emergent suicidal thoughts. Patients should be monitored closely for any of these events and seek immediate medical care if they occur.

Memantina Normon is contraindicated in patients with known hypersensitivity to memantine or any excipients. Caution is advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT